Eden Research (LON:EDEN) Shares Down 13.2% – Time to Sell?

Posted by Bob Marten on Apr 1st, 2025

Eden Research plc (LON:EDEN – Get Free Report)’s stock price traded down 13.2% during trading on Tuesday . The company traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). 1,775,147 shares were traded during mid-day trading, an increase of 133% from the average session volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Price Performance

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The stock has a fifty day simple moving average of GBX 3.39 and a two-hundred day simple moving average of GBX 3.72. The company has a market cap of £12.13 million, a PE ratio of -7.97 and a beta of 0.92.

Insider Activity

In related news, insider Alexander John Abrey bought 540,540 shares of the stock in a transaction on Tuesday, January 28th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,934.88). Also, insider Lykele van der Broek bought 256,000 shares of the company’s stock in a transaction on Thursday, February 6th. The stock was bought at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,229.97). Insiders acquired 964,487 shares of company stock valued at $3,690,001 in the last three months. 14.02% of the stock is currently owned by company insiders.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.